Diverting Loop Ileostomy: With or Without Rod (ROLLI)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Diverting ileostomies are created to protect a rectal anastomosis or in situations with a risk of intestinal perforation. Currently, the application of a rod to hinder slippage of the loop is an established technique to perform a diverting loop ileostomy. However, various "rod-less" techniques have been described and are performed with similar success. The aim of this study is to determine, whether a modification (without rod) of the current standard method of protective loop ileostomy formation (with rod) could improve ileostomy specific morbidity. Secondary endpoints include stoma care, determinants of quality of life and stoma function.
| Condition | Intervention |
|---|---|
|
Ileostomy Rectal Neoplasms |
Procedure: Diverting loop ileostomy with rod Procedure: diverting loop ileostomy without rod |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Prospective Multicenter Randomized Controlled Clinical Trial to Compare the Method of Protective Diverting Loop Ileostomy With or Without the Support of a Plastic Rod |
- Severe stoma specific morbidity rate [ Time Frame: postoperative during 2 weeks, 3 months postoperative ] [ Designated as safety issue: No ]
- postoperative during 2 weeks, 3 months postoperative [ Time Frame: postoperative during 2 weeks ] [ Designated as safety issue: Yes ]
- Time used by the stoma nurses for instructing and assisting patients [ Time Frame: preoperative, 2 weeks and 3 months postoperative ] [ Designated as safety issue: No ]
- Quality of life (QoL) by a stoma quality of life scale [ Time Frame: postoperative during 2 weeks, 3 months postoperative ] [ Designated as safety issue: No ]
- Predictive factors for stomal complications [ Time Frame: postoperative during 2 weeks, 3 months postoperative ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 180 |
| Study Start Date: | August 2008 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
A
diverting loop ileostomy with rod
|
Procedure: Diverting loop ileostomy with rod
Diverting loop ileostomy with rod
|
|
B
diverting loop ileostomy without rod
|
Procedure: diverting loop ileostomy without rod
diverting loop ileostomy without rod
|
Detailed Description:
Background
For rectal anastomoses within 6 cm of the anal verge, leakage rates are up to 15%. Here liberal use of protective stomas is widely accepted. Fecal diversion by loop ostomy may also be performed after extended adhesiolysis with serosal lesions and risk of intestinal perforation, in patients with obstructing rectal tumours requiring neoadjuvant radio-chemotherapy or in patients with complex anorectal injuries or fistulas. Generally, diverting loop ileostomies are secured at skin level by means of a supporting device in order to prevent retraction of the loop ileostomy into the abdomen. Nevertheless, due to the supporting rod, difficulties may occur in applying a stoma bag correctly and leakage of feces onto the skin may occur even with correct eversion of the afferent limb. Despite easier application of stoma bags and therefore reduced risk of skin irritation, none of these alternative techniques are established. In various non-randomized studies rodless loop ileostomies were described with an overall morbidity between 3 and 39%. However definition of morbidity varies significantly in these studies and randomised controlled trials are missing so far.
Objective
The aim of this study is to determine, whether a modification (without rod) of the current standard method of protective loop ileostomy formation (with rod) could improve ileostomy specific morbidity. Secondary endpoints include stoma care, determinants of quality of life and stoma function.
Methods
The study is designed as multi-institutional, randomized controlled, two-armed study. Patients scheduled for a protective loop ileostomy and meeting the eligibility criteria will be randomized to creation of a loop ileostomy with or without sustaining rod.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- patients scheduled for planned protective loop ileostomy
Exclusion Criteria
- patients with long-term use of corticosteroids (> 15 mg prednisolone equivalent)
- immunosuppressive agent rapamune
Contacts and Locations| Contact: Barbara Uhlmann, Study Nurse | +41 31 632 23 26 | barbara.uhlmann@insel.ch |
| Switzerland | |
| Bern University Hospital, Dep. of Visceral and Transplant Surgery | Recruiting |
| Bern, Switzerland, 3010 | |
| Contact: Lukas E Bruegger, MD +41 31 632 89 41 lukas.bruegger@insel.ch | |
| Principal Investigator: Lukas E Bruegger, MD | |
| Sub-Investigator: Vanessa Banz, MD | |
| Principal Investigator: | Lukas E Bruegger, MD | Bern University Hospital,Dep. of Visceral and Transplant Surgery Switzerland |
More Information
Publications:
| Responsible Party: | Lukas Bruegger MD, Bern University Hospital, Department of Visceral Surgery |
| ClinicalTrials.gov Identifier: | NCT00959738 History of Changes |
| Other Study ID Numbers: | 061/08 |
| Study First Received: | August 14, 2009 |
| Last Updated: | November 15, 2012 |
| Health Authority: | Switzerland: Ethikkommission |
Keywords provided by University Hospital Inselspital, Berne:
|
loop ileostomy quality of life morbidity Rectal Neoplasms |
Additional relevant MeSH terms:
|
Neoplasms Rectal Neoplasms Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms |
Neoplasms by Site Digestive System Diseases Gastrointestinal Diseases Intestinal Diseases Rectal Diseases |
ClinicalTrials.gov processed this record on May 23, 2013